Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapseMengnuo Chen, René Bernards, Sara Mainardi et al.|Cell Reports Medicine|2024Cited by 34
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary ViewDaniela E. Oprea‐Lager, Niven Mehra, Chris H. Bangma et al.|European Urology Open Science|2025Cited by 4
Discrepancies Between Global Consensus and Local Implementation in the Management of Advanced Prostate CancerNiven Mehra, Peter-Paul M. Willemse, Daniela E. Oprea-Lager et al.|European Urology Open Science|2026Cited by 0